Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 1, 2014
Reporting Period: Three months ended March 31, 2014
This filing announces the issuance of a press release regarding financial results for the quarter ended March 31, 2014, and details a related conference call held on May 1, 2014.
Key Financial Metrics
The Form 8-K text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this filing.
Material Changes
The filing does not explicitly list material changes versus the prior comparable period. It serves as a notification that results for the three months ended March 31, 2014, have been released.
Guidance, Outlook, and Risks
Management Commentary: The company held a conference call on May 1, 2014, to discuss the results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter ended March 31, 2014.
- Verify year-over-year comparisons and margin trends in the attached press release.
- Check for any forward-looking statements or guidance provided during the May 1, 2014, conference call.
- Confirm the status of the company's liquidity and debt obligations as detailed in the full financial release.